Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Clinical trial NCT01061840 · COMPLETED

Trial details

NCT number: NCT01061840
Sponsor: Gradalis, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ewings Sarcoma Non Small Cell Lung Cancer Liver Cancer

Start date: 2009-12-01
Primary completion: 2018-12-06
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.